151 related articles for article (PubMed ID: 27344367)
1. A novel cationic lipid with intrinsic antitumor activity to facilitate gene therapy of TRAIL DNA.
Luo C; Miao L; Zhao Y; Musetti S; Wang Y; Shi K; Huang L
Biomaterials; 2016 Sep; 102():239-48. PubMed ID: 27344367
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated TRAIL expression and downregulation of Bcl-2 expression suppresses non-small cell lung cancer growth in vitro and in vivo.
Zhang H; Sui A; Wang Z; Liu S; Yao R
Int J Mol Med; 2012 Aug; 30(2):358-64. PubMed ID: 22614533
[TBL] [Abstract][Full Text] [Related]
3. Recombinant adenoviruses expressing TRAIL demonstrate antitumor effects on non-small cell lung cancer (NSCLC).
Yang F; Shi P; Xi X; Yi S; Li H; Sun Q; Sun M
Med Oncol; 2006; 23(2):191-204. PubMed ID: 16720919
[TBL] [Abstract][Full Text] [Related]
4. Dual Functional LipoMET Mediates Envelope-type Nanoparticles to Combinational Oncogene Silencing and Tumor Growth Inhibition.
Shi K; Zhao Y; Miao L; Satterlee A; Haynes M; Luo C; Musetti S; Huang L
Mol Ther; 2017 Jul; 25(7):1567-1579. PubMed ID: 28274796
[TBL] [Abstract][Full Text] [Related]
5. Viral genome DNA/lipoplexes elicit in situ oncolytic viral replication and potent antitumor efficacy via systemic delivery.
Kwon OJ; Kang E; Kim S; Yun CO
J Control Release; 2011 Oct; 155(2):317-25. PubMed ID: 21699929
[TBL] [Abstract][Full Text] [Related]
6. TRAIL-based gene delivery and therapeutic strategies.
Zhong HH; Wang HY; Li J; Huang YZ
Acta Pharmacol Sin; 2019 Nov; 40(11):1373-1385. PubMed ID: 31444476
[TBL] [Abstract][Full Text] [Related]
7. Cationic liposome mediated delivery of FUS1 and hIL-12 coexpression plasmid demonstrates enhanced activity against human lung cancer.
Ren J; Yu C; Wu S; Peng F; Jiang Q; Zhang X; Zhong G; Shi H; Chen X; Su X; Luo X; Zhu W; Wei Y
Curr Cancer Drug Targets; 2014; 14(2):167-80. PubMed ID: 24410728
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of a novel recombinant mutant human tumor necrosis factor-related apoptosis-inducing ligand.
Fang F; Wang AP; Yang SF
Acta Pharmacol Sin; 2005 Nov; 26(11):1373-81. PubMed ID: 16225761
[TBL] [Abstract][Full Text] [Related]
9. Eliminating established tumor in nu/nu nude mice by a tumor necrosis factor-alpha-related apoptosis-inducing ligand-armed oncolytic adenovirus.
Dong F; Wang L; Davis JJ; Hu W; Zhang L; Guo W; Teraishi F; Ji L; Fang B
Clin Cancer Res; 2006 Sep; 12(17):5224-30. PubMed ID: 16951242
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticles evading the reticuloendothelial system: role of the supported bilayer.
Li SD; Huang L
Biochim Biophys Acta; 2009 Oct; 1788(10):2259-66. PubMed ID: 19595666
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of combination therapy using adeno-associated virus-TRAIL targeting to telomerase activity and cisplatin in a mice model of hepatocellular carcinoma.
Wang Y; Huang F; Cai H; Wu Y; He G; Tan WS
J Cancer Res Clin Oncol; 2010 Dec; 136(12):1827-37. PubMed ID: 20213096
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy sensitization by tumor-specific TRAIL gene targeting improves survival of mice bearing human non-small cell lung cancer.
Zhang X; Cheung RM; Komaki R; Fang B; Chang JY
Clin Cancer Res; 2005 Sep; 11(18):6657-68. PubMed ID: 16166445
[TBL] [Abstract][Full Text] [Related]
13. TNF-related apoptosis-inducing ligand enhances vinorelbine-induced apoptosis and antitumor activity in a preclinical model of non-small cell lung cancer.
Zhu K; Fang W; Chen Y; Lin S; Chen X
Oncol Rep; 2014 Sep; 32(3):1234-42. PubMed ID: 25017445
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antitumor effect of combining interferon beta with TRAIL mediated by tumor-targeting adeno-associated virus vector on A549 lung cancer xenograft.
Wang Y; He L; He G; Kong Y; Liu X; Cai H; Liu X; Tan W
Sheng Wu Gong Cheng Xue Bao; 2010 Jun; 26(6):780-8. PubMed ID: 20815258
[TBL] [Abstract][Full Text] [Related]
15. New path to treating pancreatic cancer: TRAIL gene delivery targeting the fibroblast-enriched tumor microenvironment.
Jiang H; Wang S; Zhou X; Wang L; Ye L; Zhou Z; Tang J; Liu X; Teng L; Shen Y
J Control Release; 2018 Sep; 286():254-263. PubMed ID: 30075209
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin enhances the antitumor effect of tumor necrosis factor-related apoptosis-inducing ligand gene therapy via recruitment of the mitochondria-dependent death signaling pathway.
Shamimi-Noori S; Yeow WS; Ziauddin MF; Xin H; Tran TL; Xie J; Loehfelm A; Patel P; Yang J; Schrump DS; Fang BL; Nguyen DM
Cancer Gene Ther; 2008 Jun; 15(6):356-70. PubMed ID: 18309355
[TBL] [Abstract][Full Text] [Related]
17. A bispecific fusion protein and a bifunctional enediyne-energized fusion protein consisting of TRAIL, EGFR peptide ligand, and apoprotein of lidamycin against EGFR and DR4/5 show potent antitumor activity.
Zhu D; Wang X; Shang Y; Li Y; Jiang W; Li L; Chen SZ
Anticancer Drugs; 2015 Jan; 26(1):64-73. PubMed ID: 25122444
[TBL] [Abstract][Full Text] [Related]
18. TRAIL-coated lipid-nanoparticles overcome resistance to soluble recombinant TRAIL in non-small cell lung cancer cells.
De Miguel D; Gallego-Lleyda A; Ayuso JM; Erviti-Ardanaz S; Pazo-Cid R; del Agua C; Fernández LJ; Ochoa I; Anel A; Martinez-Lostao L
Nanotechnology; 2016 May; 27(18):185101. PubMed ID: 27001952
[TBL] [Abstract][Full Text] [Related]
19. Structure-transfection activity relationships in a series of novel cationic lipids with heterocyclic head-groups.
Ivanova EA; Maslov MA; Kabilova TO; Puchkov PA; Alekseeva AS; Boldyrev IA; Vlassov VV; Serebrennikova GA; Morozova NG; Zenkova MA
Org Biomol Chem; 2013 Nov; 11(41):7164-78. PubMed ID: 24057052
[TBL] [Abstract][Full Text] [Related]
20. LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth.
Whitmore M; Li S; Huang L
Gene Ther; 1999 Nov; 6(11):1867-75. PubMed ID: 10602382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
